Sheba Medical Center Affiliated Principal Investigator Discusses the Successful Ivermectin Study for Mild COVID-19

Sheba Medical Center Affiliated Principal Investigator Discusses the Successful Ivermectin Study for Mild COVID-19

Recently, Professor Eli Schwarz, the Director of the Center for Geographic Medicine at Sheba Medical Center in Tel-Hashomer, Israel, reported on the success of a randomly controlled, double-blind clinical trial showing that the generic drug ivermectin materially reduces COVID-19 viral shedding. Professional Schwarz was recently interviewed for BizNews Radio in South Africa to report on his study’s findings. In a nutshell—while he acknowledges that, of course, more research is vital that public health authorities and apex research bodies should be funding such initiatives now. His study, well designed and conducted in one of the top health centers in the world, reveals that, in fact, ivermectin does reduce viral shedding overall in patients with COVID-19. Although the patient sample was not sufficiently sized, the data did reveal that the off-label FDA-approved drug can reduce infectivity duration.

TrialSite recommends listeners with the time tune into this brief interview with Professor Eli Schwarz. Noting that at the time he commenced this study, the world was embracing hydroxychloroquine; his effort was based on the initial lab findings in Australia at University of Monash an...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee